Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment
暂无分享,去创建一个
Bruno Alfano | Mario Quarantelli | Roberta Lanzillo | Marco Comerci | Marcello Moccia | Rosario Megna | Giuseppe Servillo | B. Alfano | A. Prinster | M. Quarantelli | G. Servillo | A. Carotenuto | G. Vacca | V. Brescia Morra | M. Moccia | M. Comerci | Anna Prinster | Vincenzo Brescia Morra | R. Lanzillo | R. Megna | T. Costabile | Antonio Carotenuto | Teresa Costabile | Giovanni Vacca
[1] Mark D. Does,et al. Inferring brain tissue composition and microstructure via MR relaxometry , 2018, NeuroImage.
[2] David H. Miller,et al. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. , 2010, Brain : a journal of neurology.
[3] Mário João Fartaria,et al. The Combined Quantification and Interpretation of Multiple Quantitative Magnetic Resonance Imaging Metrics Enlightens Longitudinal Changes Compatible with Brain Repair in Relapsing-Remitting Multiple Sclerosis Patients , 2017, Front. Neurol..
[4] Oliver Bieri,et al. Assessing White Matter Microstructure in Brain Regions with Different Myelin Architecture Using MRI , 2016, PloS one.
[5] R. Ordidge,et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis , 2003, Journal of Neurology.
[6] F. Barkhof,et al. High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis , 2016, Multiple sclerosis.
[7] David H. Miller,et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain , 2004, Annals of neurology.
[8] J. Thiran,et al. Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis , 2014, Annals of Clinical and Translational Neurology.
[9] J. DeLuca,et al. Cognitive impairment in multiple sclerosis , 2008, The Lancet Neurology.
[10] Massimo Filippi,et al. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis , 2015, The Lancet Neurology.
[11] C. Pozzilli,et al. No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing–remitting multiple sclerosis (the ARIANNA study) , 2016, Multiple sclerosis.
[12] C. Laule,et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology , 2006, Multiple sclerosis.
[13] Rohit Bakshi,et al. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. , 2004, Archives of neurology.
[14] Hui Jing Yu,et al. Multiple white matter tract abnormalities underlie cognitive impairment in RRMS , 2012, NeuroImage.
[15] Bruno Alfano,et al. A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain , 2015, PloS one.
[16] J. Thiran,et al. Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis , 2015, BioMed research international.
[17] M Quarantelli,et al. A voxel-based morphometry study of disease severity correlates in relapsing–remitting multiple sclerosis , 2010, Multiple sclerosis.
[18] Rajiv Midha,et al. MR properties of excised neural tissue following experimentally induced inflammation , 2004, Magnetic resonance in medicine.
[19] Bruno Alfano,et al. Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis , 2000 .
[20] G. Siracusa,et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis , 2008, Neurology.
[21] T. Ptak,et al. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. , 1999, AJNR. American journal of neuroradiology.
[22] S. Sorbi,et al. The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population , 2006, Multiple sclerosis.
[23] E. Capitani,et al. A normative study on visual reaction times and two Stroop colour-word tests , 1998, The Italian Journal of Neurological Sciences.
[24] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[25] J. Thiran,et al. MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis , 2014, Journal of Neurology.
[26] M. Ron,et al. Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[27] Bruno Alfano,et al. Grey matter loss in relapsing–remitting multiple sclerosis: A voxel-based morphometry study , 2006, NeuroImage.
[28] G. Tedeschi,et al. Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing— remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy , 2010, Multiple sclerosis.
[29] D. Louis Collins,et al. Quantitative Magnetic Resonance Imaging of Cortical Multiple Sclerosis Pathology , 2012, Multiple sclerosis international.
[30] M Filippi,et al. Magnetisation transfer imaging: theory and application to multiple sclerosis. , 1998, Journal of neurology, neurosurgery, and psychiatry.
[31] Rohit Bakshi,et al. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis , 2006, Neurology.
[32] A. Lutti,et al. Advances in MRI-based computational neuroanatomy: from morphometry to in-vivo histology. , 2015, Current opinion in neurology.
[33] Hans Lassmann,et al. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.
[34] Christian Enzinger,et al. Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis , 2015, NeuroImage: Clinical.
[35] C. Jacobsen,et al. MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge , 2014, Acta neurologica Scandinavica. Supplementum.
[36] Jie Luo,et al. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI , 2015, NeuroImage: Clinical.
[37] L. Leocani,et al. Clinical and MRI assessment of brain damage in MS , 2001, Neurological Sciences.
[38] B. Mädler,et al. MR relaxation in multiple sclerosis. , 2009, Neuroimaging clinics of North America.
[39] M. Calabrese,et al. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment , 2010, Neurology.
[40] F. Jolesz,et al. In vivo characterization of cytotoxic intracellular edema by multicomponent analysis of transverse magnetization decay curves. , 1995, Academic radiology.
[41] Bruno Alfano,et al. Simultaneous Display of Multiple MR Parameters with “Quantitative Magnetic Color Imaging” , 1992, Journal of computer assisted tomography.